Non-Invasive Prenatal Testing (NIPT) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Get in-depth COVID-19 impact and recovery analysis on the Non Invasive Prenatal Testing Market

Flash Discount
15% Single User
20% Multi User
25% Corporate
30% Enterprise
  • Summary

    Further key aspects of the report indicate that:

    Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology

    Chapter 2: Global Industry Summary

    Chapter 3: Market Dynamics

    Chapter 4: Global Market Segmentation by region, type and End-Use

    Chapter 5: North America Market Segmentation by region, type and End-Use

    Chapter 6: Europe Market Segmentation by region, type and End-Use

    Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use

    Chapter 8: South America Market Segmentation by region, type and End-Use

    Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.

    Chapter 10: Market Competition by Companies

    Chapter 11: Market forecast and environment forecast.

    Chapter 12: Industry Summary.

    The global Non-Invasive Prenatal Testing (NIPT) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

    Based on the type of product, the global Non-Invasive Prenatal Testing (NIPT) market segmented into

    Ultrasound Detection

    Biochemical Screening Tests

    Cell-Free Dna In Maternal Plasma Tests

    Fetal Cells In Maternal Blood Tests

    Others

    Based on the end-use, the global Non-Invasive Prenatal Testing (NIPT) market classified into

    Hospitals

    Clinics

    Research Laboratories

    Based on geography, the global Non-Invasive Prenatal Testing (NIPT) market segmented into

    North America [U.S., Canada, Mexico]

    Europe [Germany, UK, France, Italy, Rest of Europe]

    Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]

    South America [Brazil, Argentina, Rest of Latin America]

    Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

    And the major players included in the report are

    GE Healthcare

    Koninklijke Philips

    BGI Genomics

    Illumina

    Thermo Fisher Scientific

    F. Hoffmann-La Roche

    Pacific Biosciences Of California

    Perkinelmer

    Qiagen

    Agilent Technologies

    LifeCodexx

    Berry Genomics

    LifeLabs Genetics

    Quest Diagnostics

    Safembryo

    Laboratory Corporation of America Holdings

    Natera

    Sequenom

    Ariosa Diagnostics

    CombiMatrix

     

  • With tables and figures helping analyze worldwide Non Invasive Prenatal Testing (NIPT) market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


    1 RESEARCH SCOPE

    1.1 Research Product Definition

    1.2 Research Segmentation

    1.2.1 Product Type
    1.2.2 Main product Type of Major Players

    1.3 Demand Overview

    1.4 Research Methodology


    2 GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) INDUSTRY

    2.1 Summary about Non-Invasive Prenatal Testing (NIPT) Industry

    2.2 Non-Invasive Prenatal Testing (NIPT) Market Trends

    2.2.1 Non-Invasive Prenatal Testing (NIPT) Production & Consumption Trends
    2.2.2 Non-Invasive Prenatal Testing (NIPT) Demand Structure Trends

    2.3 Non-Invasive Prenatal Testing (NIPT) Cost & Price


    3 MARKET DYNAMICS

    3.1 Manufacturing & Purchasing Behavior in 2020

    3.2 Market Development under the Impact of COVID-19

    3.2.1 Drivers
    3.2.2 Restraints
    3.2.3 Opportunity
    3.2.4 Risk

    4 GLOBAL MARKET SEGMENTATION

    4.1 Region Segmentation (2017 to 2021f)

    4.1.1 North America (U.S., Canada and Mexico)
    4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
    4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
    4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
    4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

    4.2 Product Type Segmentation (2017 to 2021f)

    4.2.1 Ultrasound Detection
    4.2.2 Biochemical Screening Tests
    4.2.3 Cell-Free Dna In Maternal Plasma Tests
    4.2.4 Fetal Cells In Maternal Blood Tests
    4.2.5 Others

    4.3 Consumption Segmentation (2017 to 2021f)

    4.3.1 Hospitals
    4.3.2 Clinics
    4.3.3 Research Laboratories

    5 NORTH AMERICA MARKET SEGMENT

    5.1 Region Segmentation (2017 to 2021f)

    5.1.1 U.S.
    5.1.2 Canada
    5.1.3 Mexico

    5.2 Product Type Segmentation (2017 to 2021f)

    5.2.1 Ultrasound Detection
    5.2.2 Biochemical Screening Tests
    5.2.3 Cell-Free Dna In Maternal Plasma Tests
    5.2.4 Fetal Cells In Maternal Blood Tests
    5.2.5 Others

    5.3 Consumption Segmentation (2017 to 2021f)

    5.3.1 Hospitals
    5.3.2 Clinics
    5.3.3 Research Laboratories

    5.4 Impact of COVID-19 in North America


    6 EUROPE MARKET SEGMENTATION

    6.1 Region Segmentation (2017 to 2021f)

    6.1.1 Germany
    6.1.2 UK
    6.1.3 France
    6.1.4 Italy
    6.1.5 Rest of Europe

    6.2 Product Type Segmentation (2017 to 2021f)

    6.2.1 Ultrasound Detection
    6.2.2 Biochemical Screening Tests
    6.2.3 Cell-Free Dna In Maternal Plasma Tests
    6.2.4 Fetal Cells In Maternal Blood Tests
    6.2.5 Others

    6.3 Consumption Segmentation (2017 to 2021f)

    6.3.1 Hospitals
    6.3.2 Clinics
    6.3.3 Research Laboratories

    6.4 Impact of COVID-19 in Europe


    7 ASIA-PACIFIC MARKET SEGMENTATION

    7.1 Region Segmentation (2017 to 2021f)

    7.1.1 China
    7.1.2 India
    7.1.3 Japan
    7.1.4 South Korea
    7.1.5 Southeast Asia
    7.1.6 Australia
    7.1.7 Rest of Asia Pacific

    7.2 Product Type Segmentation (2017 to 2021f)

    7.2.1 Ultrasound Detection
    7.2.2 Biochemical Screening Tests
    7.2.3 Cell-Free Dna In Maternal Plasma Tests
    7.2.4 Fetal Cells In Maternal Blood Tests
    7.2.5 Others

    7.3 Consumption Segmentation (2017 to 2021f)

    7.3.1 Hospitals
    7.3.2 Clinics
    7.3.3 Research Laboratories

    7.4 Impact of COVID-19 in Europe


    8 SOUTH AMERICA MARKET SEGMENTATION

    8.1 Region Segmentation (2017 to 2021f)

    8.1.1 Brazil
    8.1.2 Argentina
    8.1.3 Rest of Latin America

    8.2 Product Type Segmentation (2017 to 2021f)

    8.2.1 Ultrasound Detection
    8.2.2 Biochemical Screening Tests
    8.2.3 Cell-Free Dna In Maternal Plasma Tests
    8.2.4 Fetal Cells In Maternal Blood Tests
    8.2.5 Others

    8.3 Consumption Segmentation (2017 to 2021f)

    8.3.1 Hospitals
    8.3.2 Clinics
    8.3.3 Research Laboratories

    8.4 Impact of COVID-19 in Europe


    9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

    9.1 Region Segmentation (2017 to 2021f)

    9.1.1 GCC
    9.1.2 North Africa
    9.1.3 South Africa
    9.1.4 Rest of Middle East and Africa

    9.2 Product Type Segmentation (2017 to 2021f)

    9.2.1 Ultrasound Detection
    9.2.2 Biochemical Screening Tests
    9.2.3 Cell-Free Dna In Maternal Plasma Tests
    9.2.4 Fetal Cells In Maternal Blood Tests
    9.2.5 Others

    9.3 Consumption Segmentation (2017 to 2021f)

    9.3.1 Hospitals
    9.3.2 Clinics
    9.3.3 Research Laboratories

    9.4 Impact of COVID-19 in Europe


    10 COMPETITION OF MAJOR PLAYERS

    10.1 Brief Introduction of Major Players

    10.1.1 GE Healthcare
    10.1.2 Koninklijke Philips
    10.1.3 BGI Genomics
    10.1.4 Illumina
    10.1.5 Thermo Fisher Scientific
    10.1.6 F. Hoffmann-La Roche
    10.1.7 Pacific Biosciences Of California
    10.1.8 Perkinelmer
    10.1.9 Qiagen
    10.1.10 Agilent Technologies
    10.1.11 LifeCodexx
    10.1.12 Berry Genomics
    10.1.13 LifeLabs Genetics
    10.1.14 Quest Diagnostics
    10.1.15 Safembryo
    10.1.16 Laboratory Corporation of America Holdings
    10.1.17 Natera
    10.1.18 Sequenom
    10.1.19 Ariosa Diagnostics
    10.1.20 CombiMatrix

    10.2 Non-Invasive Prenatal Testing (NIPT) Sales Date of Major Players (2017-2020e)

    10.2.1 GE Healthcare
    10.2.2 Koninklijke Philips
    10.2.3 BGI Genomics
    10.2.4 Illumina
    10.2.5 Thermo Fisher Scientific
    10.2.6 F. Hoffmann-La Roche
    10.2.7 Pacific Biosciences Of California
    10.2.8 Perkinelmer
    10.2.9 Qiagen
    10.2.10 Agilent Technologies
    10.2.11 LifeCodexx
    10.2.12 Berry Genomics
    10.2.13 LifeLabs Genetics
    10.2.14 Quest Diagnostics
    10.2.15 Safembryo
    10.2.16 Laboratory Corporation of America Holdings
    10.2.17 Natera
    10.2.18 Sequenom
    10.2.19 Ariosa Diagnostics
    10.2.20 CombiMatrix

    10.3 Market Distribution of Major Players

    10.4 Global Competition Segmentation


    11 MARKET FORECAST

    11.1 Forecast by Region

    11.2 Forecast by Demand

    11.3 Environment Forecast

    11.3.1 Impact of COVID-19
    11.3.2 Geopolitics Overview
    11.3.3 Economic Overview of Major Countries

    12 REPORT SUMMARY STATEMENT

     

  • The Non Invasive Prenatal Testing (NIPT) Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
    • GE Healthcare
    • Koninklijke Philips
    • BGI Genomics
    • Illumina
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche
    • Pacific Biosciences Of California
    • Perkinelmer
    • Qiagen
    • Agilent Technologies
    • LifeCodexx
    • Berry Genomics
    • LifeLabs Genetics
    • Quest Diagnostics
    • Safembryo
    • Laboratory Corporation of America Holdings
    • Natera
    • Sequenom
    • Ariosa Diagnostics
    • CombiMatrix
    By Regions:
    • North America [U.S., Canada, Mexico]
    • Europe [Germany, UK, France, Italy, Rest of Europe]
    • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
    • South America [Brazil, Argentina, Rest of Latin America]
    • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
    By Type:
    • Ultrasound Detection
    • Biochemical Screening Tests
    • Cell-Free Dna In Maternal Plasma Tests
    • Fetal Cells In Maternal Blood Tests
    • Others
    By Application:
    • Hospitals
    • Clinics
    • Research Laboratories
Licensing options
3000
USD

Need assistance ?

Related reports

Research objectives

Where will all these developments take the industry in the long

To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

What are the future opportunities in the market?

To understand the structure of Market by identifying its various subsegments.

What are the major driving forces expected to impact the development of the market market across different regions?

To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

To project the consumption of market submarkets, with respect to key regions.

Who are the major driving forces expected to decide the fate of the industry worldwide.

To strategically profile the key players and comprehensively analyze their growth strategies.

What are the key barriers and threats believed to hinder the development of the industry?

To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

Who are the prominent market players making a mark in the market with their winning strategies?

To share detailed information about the key factors influencing the growth of the market

What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

Our Clients